Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort

Clin J Am Soc Nephrol. 2010 Oct;5(10):1815-20. doi: 10.2215/CJN.00300110. Epub 2010 Jul 29.

Abstract

Background and objectives: As a result of improved clinical and quality-of-life outcomes compared with conventional hemodialysis, interest in nocturnal home hemodialysis (NHD) has steadily increased in the past decade; however, little is known about the flow of patients through NHD programs or about patient-specific predictors of mortality or technique failure associated with this modality. This study addressed this gap in knowledge.

Design, setting, participants, & measurements: This study included 247 NHD patients of the Canadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP) cohort from 1994 through 2006 inclusive. The association between program- and patient-specific variables and risk for adverse outcomes was determined using uni- and multivariable Cox regression.

Results: A total of 14.6% of the cohort experienced death or technique failure. Unadjusted 1- and 5-year adverse event-free survival was 95.2 and 80.1%, respectively. Significant predictors of a composite of mortality and technique failure included advanced age (P < 0.001), diabetes (P < 0.001), central venous catheter use (P = 0.01), and inability to perform NHD independently (P = 0.009) and were adjusted for center effect. Weekly frequency of NHD was not predictive. Age and diabetes remained significant with multivariable analysis (hazard ratio 1.07 and 2.64, respectively). Unadjusted 1- and 5-year technique survival was 97.9 and 95.2%, respectively. Only age was a significant predictor of technique failure.

Conclusions: NHD is associated with excellent adverse event-free survival. This study underscores the importance of modality-specific predictors in the success of home hemodialysis, as well as favorable baseline characteristics such as younger age and the absence of diabetes.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Age Factors
  • Canada
  • Catheterization, Central Venous / adverse effects
  • Cohort Studies
  • Diabetes Mellitus / mortality
  • Disease-Free Survival
  • Female
  • Hemodialysis, Home / adverse effects*
  • Hemodialysis, Home / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care* / statistics & numerical data
  • Program Evaluation
  • Proportional Hazards Models
  • Registries
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Failure